Code | 3575E | ||||||||||
MA number | 42/0114/23-S | ||||||||||
Product Form: | cps mdd 20x100 mg (blis.PVC/Aclar/Al) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | AS Olainfarm, Latvia | ||||||||||
Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister PVC/Aclar/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 02.05.2023 |
Validity: | 02.05.2028 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric contraindication: | Yes |
SPC: | SPC_Nostiriazyn 100 mg tvrdé kapsuly s riadeným uvoľňovaním_03.2024.pdf |
PIL: | PIL_Nostiriazyn 100 mg tvrdé kapsuly s riadeným uvoľňovaním_10.2023.pdf |
Safety feature | Yes |
Data update: | 25.03.2024 |